DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival

References

• D’AngeloEPratJUterine sarcomas: a reviewGynecol Oncol2010116113113919853898
   PubMed Web of Science ®Google Scholar
• ZhiqiangLBinSMinFYufangLLeiomyosarcoma of cervical stump following subtotal hysterectomy: a case report and review of literatureEur J Gynaecol Oncol201637114815127048131
   PubMedGoogle Scholar
• KhoslaDGuptaRSrinivasanRPatelFDRajwanshiASarcomas of uterine cervix: clinicopathological features, treatment, and outcomeInt J Gynecol Cancer20122261026103022740005
   PubMedGoogle Scholar
• BollDVerhoevenRHvan der AaMAIncidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989–2008Int J Gynecol Cancer201222459960622398706
   PubMedGoogle Scholar
• AmantFCoosemansADebiec-RychterMTimmermanDVergoteIClinical management of uterine sarcomasLancet Oncol200910121188119819959075
   PubMed Web of Science ®Google Scholar
• GottliebSTamoxifen may increase risk for uterine sarcomaBr Med J20023257
   PubMed Web of Science ®Google Scholar
• NaamanYShveikyDBen-ShacharIShushanAMejia-GomezJBenshushanAUterine sarcoma: prognostic factor and treatment evaluationIsr Med Assoc J2011132767921443030
   PubMedGoogle Scholar
• NCCN Clinical Practice Guidelines in Oncology. Uterine Neoplasms. Version 22016 Accessed from: www.nccn.orgAccessed December 7, 2016
   Google Scholar
• CramerSFPatelAThe frequency of uterine leiomyomasAm J Clin Pathol19909444354382220671
   PubMed Web of Science ®Google Scholar
• MittalKJoutovskyAAreas with benign morphologic and immunohistochemical features are associated with some uterine leiomyosarcomasGynecol Oncol2007104236236517011615
   PubMedGoogle Scholar
• MittalKPrecursor lesions for uterine leiomyosarcomaHum Pathol20073881289
   PubMedGoogle Scholar
• ZhangPZhangCHaoJUse of X-chromosome inactivation pattern to determine the clonal origins of uterine leiomyoma and leiomyosarcomaHum Pathol200637101350135616949924
   PubMedGoogle Scholar
• GadducciASartoriELandoniFThe prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 casesEur J Gynaecol Oncol200223429528912214727
   PubMedGoogle Scholar
• RaspolliniMRAmunniGVillanucciAEstrogen and progesterone receptors expression in uterine malignant smooth muscle tumors: correlation with clinical outcomeJ Chemother200315659660214998087
   PubMed Web of Science ®Google Scholar
• SmirnovaISYakovlevaTKRosanovYMAksenovNDPospelovaTVAnalysis of p53-dependent mechanisms in the maintenance of genetic stability in diploid tumourigenic line SK-UT-1B of human uterine leiomyosarcomaCell Biol Int200125111101111511913954
   PubMedGoogle Scholar
• KułakKBobińskiMPolakGJedrychBJKotarskiJBednarekWOcena ekspresji kaspazy 9 i bialka p53 w miesakach macicy. [Expression of caspase 9 and p53 in uterine leiomyosarcomas]Ginekol Pol2014858600604 Polish25219140
   PubMedGoogle Scholar
• BodnerKBodner-AdlerBKimbergerOCzerwenkaKMayerhoferKBcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcomaWien Klin Wochenschr2004116413513915038405
   PubMedGoogle Scholar
• KowalewskaMBakula-ZalewskaEChechlinskaMmicroRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary reportTumour Biol20133442153216023558962
   PubMedGoogle Scholar
• BarlinJNZhouQCLeitaoMMMolecular subtypes of uterine leiomyosarcoma and correlation with clinical outcomeNeoplasia201517218318925748237
   PubMed Web of Science ®Google Scholar
• CekanovaMFernandoRISiriwardhanaNBCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasionExp Cell Res2015331111025499972
   PubMedGoogle Scholar
• ChaudhryPSrinivasanRPatelFDDifferential expression of Fas family members and Bcl-2 family members in benign versus malignant epithelial ovarian cancer (EOC) in North Indian populationMol Cell Biochem20123681–211912622688594
   PubMedGoogle Scholar
• DorjgochooTXiangYBLongJAssociation of genetic markers in the BCL-2 family of apoptosis-related genes with endometrial cancer risk in a Chinese populationPLoS One201384e6091523637776
   PubMedGoogle Scholar
• MaoPLJiangYWeeBYPorterAGActivation of caspase-1 in the nucleus requires nuclear translocation of pro-caspase-1 mediated by its prodomainJ Biol Chem19982733723621236249726961
   PubMedGoogle Scholar
• FukushimaKKikuchiJKoshibaSKigawaTKurodaYYokoyamaSSolution structure of the DFF-C domain of DFF45/ICAD. A structural basis for the regulation of apoptotic DNA fragmentationJ Mol Biol2002321231732712144788
   PubMedGoogle Scholar
• SchorrKLiMKrajewskiSReedJCFurthPABcl-2 gene family and related proteins in mammary gland involution and breast cancerJ Mammary Gland Biol Neoplasia19994215316410426394
   PubMedGoogle Scholar
• KhodapasandEJafarzadehNFarrokhiFKamalidehghanBHoushmandMIs Bax/Bcl-2 ratio considered as a prognostic marker with age and tumor location in colorectal cancer?Iran Biomed J2015192697525864810
   PubMedGoogle Scholar
• NakamuraTNomuraSSakaiTNariyaSExpression of bcl-2 oncoprotein in gastrointestinal and uterine carcsinomas and their premalignant lesionsHum Pathol19972833093159042795
   PubMedGoogle Scholar
• GeislerJPGeislerHEWiemannMCZhouZMillerGACrabtreeWLack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinomaGynecol Oncol19987123053079826476
   PubMedGoogle Scholar
• HwangKTHanWKimJPrognostic influence of BCL2 on molecular subtypes of breast cancerJ Breast Cancer2017201546428382095
   PubMedGoogle Scholar
• PorichiONikolaidouMEApostolakiABCL-2, BAX and P53 expression profiles in endometrial carcinoma as studied by real-time PCR and immunohistochemistryAnticancer Res200929103977398219846939
   PubMedGoogle Scholar
• GeislerJPGeislerHEWiemannMCZhouZMillerGACrabtreeWLack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinomaGynecol Oncol19987123053079826476
   PubMedGoogle Scholar
• ZhaiYLNikaidoTTokiTShiozawaAOriiAFujiiSPrognostic significance of bcl-2 expression in leiomyosarcoma of the uterusBr J Cancer199980101658166410408415
   PubMedGoogle Scholar
• RajandramRRazackAHNgKLGobeGCDecreased expression of inhibitor of caspase-activated DNase (ICAD) in renal cell carcinoma – tissue microarray of human samplesJ Kidney Cancer VHL201631111
   PubMedGoogle Scholar
• KonishiSIshiguroHShibataYDecreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinomaCancer200295122473247812467059
   PubMedGoogle Scholar
• ErramiYBrimHOumouna-BenachourKICAD deficiency in human colon cancer and predisposition to colon tumorigenesis: linkage to apoptosis resistance and genomic instabilityPLoS One201382e5787123451280
   PubMedGoogle Scholar
• BanasTBastaPKnafelADFF45 expression in human endometrium is associated with menstrual cycle phases and decreases after menopauseGynecol Obstet Invest20127317718222378161
   PubMedGoogle Scholar
• BanasTSkotnicznyKBastaADFF45 expression in ovarian endometriomasEur J Obstet Gynecol Reprod Biol20091461879119535198
   PubMedGoogle Scholar
• RemmeleWStegnerHERecommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissuePathologe198783138140 Article in German3303008
   PubMed Web of Science ®Google Scholar
• PreacherKJCalculation for the chi-square test: an interactive calculation tool for chi-square tests of goodness of fit and independence [Computer software] Available from: http://quantpsy.orgAccessed January 2, 2017
   Google Scholar
• KottnerJAudigeLBrorsonSGuidelines for reporting reliability and agreement studies (GRRAS) were proposedInt J Nurs Stud201148666167121514934
   PubMed Web of Science ®Google Scholar
• KobayashiHUekuriCAkasakaJThe biology of uterine sarcomas: a review and updateMol Clin Oncol20131459960924649216
   PubMedGoogle Scholar
• LeiserALAndersonSENonakaDApoptotic and cell cycle regulatory markers in uterine leiomyosarcomaGynecol Oncol20061011869116289259
   PubMedGoogle Scholar
• D’AngeloEEspinosaIAliRUterine leiomyosarcomas: tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosisGynecol Oncol2011121232833321316747
   PubMedGoogle Scholar
• Sánchez-OsunaMMartínez-EscardóLGranados-ColominaCAn intrinsic DFF40/CAD endonuclease deficiency impairs oligonucleosomal DNA hydrolysis during caspase-dependent cell death: a common trait in human glioblastoma cellsNeuro Oncol201618795096126755073
   PubMedGoogle Scholar
• BagheriFSafarianSEslaminejadMBSheibaniNSensitization of breast cancer cells to doxorubicin via stable cell line generation and overexpression of DFF40Biochem Cell Biol201593660461026529233
   PubMedGoogle Scholar
• BoonSSSimSPInhibitor of caspase-activated DNase expression enhances caspase-activated DNase expression and inhibits oxidative stress-induced chromosome breaks at the mixed lineage leukaemia gene in nasopharyngeal carcinoma cellsCancer Cell Int2015155426019688
   PubMedGoogle Scholar
• BrustmannHDNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancerPathol Res Pract20062021071372016962250
   PubMedGoogle Scholar
• BrustmannHPoly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissuesPathol Res Pract20072032657217258405
   PubMedGoogle Scholar
• NagataSApoptosis by death factorCell19978833553569039262
   PubMed Web of Science ®Google Scholar
• LeistMJäätteläMFour deaths and a funeral: from caspases to alternative mechanismsNat Rev Mol Cell Biol20012858959811483992
   PubMed Web of Science ®Google Scholar
• BerridgeMJLippPBootmanMDThe versatility and universality of calcium signalingNat Rev Mol Cell Biol200011112111413485
   PubMed Web of Science ®Google Scholar